1-3
2026
影响因子区间
—
平台估算
39%
2025
中国作者发文占比
—
收费
期刊简介:Biotechnology Letters is the world’s leading rapid-publication primary journal dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them.All relevant aspects of molecular biology, genetics and cell biochemistry, of process and reactor design, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included.Contributions from industrial and academic laboratories are equally welcome. We also welcome contributions covering biotechnological aspects of regenerative medicine and biomaterials and also cancer biotechnology. Criteria for the acceptance of papers relate to our aim of publishing useful and informative results that will be of value to other workers in related fields.The emphasis is very much on novelty and immediacy in order to justify rapid publication of authors’ results. It should be noted, however, that we do not normally publish papers (but this is not absolute) that deal with unidentified consortia of microorganisms (e.g. as in activated sludge) as these results may not be easily reproducible in other laboratories.Papers describing the isolation and identification of microorganisms are not regarded as appropriate but such information can be appended as supporting information to a paper. Papers dealing with simple process development are usually considered to lack sufficient novelty or interest to warrant publication.
【译文】《生物技术通讯》是全球领先的快速发表生物技术领域的首要期刊,涵盖与微生物、植物或动物细胞及其衍生的生物催化剂相关的实际或潜在应用的所有相关主题。因此,包括分子生物学、遗传学和细胞生物化学、工艺和反应器设计、预处理和后处理步骤以及制造或服务操作的所有相关方面。工业和学术实验室的贡献都受到欢迎。我们还欢迎涵盖再生医学和生物材料以及癌症生物技术的生物技术方面的贡献。论文接受的标准与我们的目标有关,即出版有用和有信息量的结果,这些结果将对相关领域的其他工作者有价值。重点非常放在新颖性和即时性上,以便为作者结果的快速发表提供正当理由。然而,请注意,我们通常不发表处理未知的微生物群体(例如,在活性污泥中)的论文(但这并非绝对),因为这些结果可能不易在其他实验室中重复。描述微生物分离和鉴定的论文通常被认为缺乏足够的创新或兴趣,不足以保证发表。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |